Kyverna Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
KYTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5980 Horton Street, Suite 550, Emeryville, CA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Kyverna Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner Feb 12, 2024
Brian L. Kotzin Director Feb 7, 2024
James Bum Chung Chief Medical Officer Feb 7, 2024
Karen Walker Chief Technology Officer Jun 6, 2024
Northpond Ventures III GP, LLC Former 10% Owner Feb 12, 2024
Bain Capital Life Sciences Investors, LLC 10%+ Owner Feb 12, 2024
Westlake BioPartners Fund I, L.P. 10%+ Owner Feb 12, 2024
Peter Maag Chief Executive Officer, Director Feb 7, 2024
Beth C. Seidenberg Director, 10%+ Owner Feb 12, 2024
Ryan Jones Chief Financial Officer May 28, 2024
Vida Ventures, LLC 10%+ Owner Feb 12, 2024
Fred E. Cohen Director, 10%+ Owner Feb 12, 2024
Ian T. Clark Director Feb 7, 2024
Dominique Christian Borie President, Research and Development Exhibit 24 - Power of Attorney Feb 7, 2024
Daniel K. Spiegelman Director Feb 7, 2024
Stephen Constantine Liapis Director Feb 7, 2024
Warner Weston Biddle Chief Executive Officer, Director Sep 16, 2024
Christi Shaw Director Sep 16, 2024
Mert Aktar Director Oct 21, 2024

Recent Insider Transactions by Companies or Individuals for Kyverna Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.